Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-29 06:17 am Sale | 2024-12-31 | 13G | Immix Biopharma, Inc. IMMX | HIRSCHMAN ORIN | 0 0.000% | -1,455,000 (Position Closed) | Filing History |
| 2024-02-07 09:18 am Purchase | 2024-02-06 | 13G | Immix Biopharma, Inc. IMMX | HIRSCHMAN ORIN | 1,455,000 5.800% | 1,455,000 (New Position) | Filing History |
| 2023-08-30 4:15 pm Purchase | 2023-08-21 | 13D | Immix Biopharma, Inc. IMMX | GKCC LLC | 3,255,734 19.990% | 3,255,734 (New Position) | Filing History |
| 2022-03-02 2:57 pm Sale | 2022-02-25 | 13G | Immix Biopharma, Inc. IMMX | Murchinson Ltd. | 0 0.000% | -695,600 (Position Closed) | Filing History |
| 2022-02-11 06:22 am Sale | 2021-12-31 | 13G | Immix Biopharma, Inc. IMMX | Altium Capital Management LLC | 122,388 1.600% | -551,995 (-81.85%) | Filing History |
| 2022-02-09 5:12 pm Purchase | 2021-12-31 | 13G | Immix Biopharma, Inc. IMMX | Murchinson Ltd. | 695,600 5.280% | 695,600 (New Position) | Filing History |
| 2021-12-27 6:06 pm Purchase | 2021-12-16 | 13G | Immix Biopharma, Inc. IMMX | Altium Capital Management LLC | 674,383 8.200% | 674,383 (New Position) | Filing History |